References
- FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365e359e38625220842
- JiangXTangHChenTEpidemiology of gynecologic cancers in ChinaJ Gynecol Oncol2018291e729185265
- ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
- US Preventive Services Task ForceCurrySJKristAHScreening for cervical cancer: US Preventive Services Task Force Recommendation StatementJAMA2018320767468630140884
- ChelmowDCervical cancer screening and preventionAm Coll Obstet Gynecol2016128923925
- SaslowDSolomonDLawsonHWAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerCA Cancer J Clin201262314717222422631
- RoncoGDillnerJElfströmKMEfficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trialsLancet2014383991652453224192252
- MeijerCJBerkhofJCastlePEGuidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderInt J Cancer2009124351652018973271
- WalboomersJMJacobsMVManosMMHuman papillomavirus is a necessary cause of invasive cervical cancer worldwideJ Pathol19991891121910451482
- MeijerCJSnijdersPJCastlePEClinical utility of HPV genotypingGynecol Oncol20061031121716934860
- GuanPHowell-JonesRLiNHuman papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancerInt J Cancer2012131102349235922323075
- BouvardVBaanRStraifKA review of human carcinogens–Part B: biological agentsLancet Oncol200910432132219350698
- Diane SolomonDDKurmanRMoriartyAThe 2001 Bethesda SystemJAMA20022872114211911966386
- YouensKEHoslerGAWashingtonPJJeneveinEPMurphyKMClinical experience with the Cervista HPV HR assay: correlation of cytology and HPV status from 56,501 specimensJ Mol Diagn201113216016621354050
- LiYHuangKJiPLSongLLiuHTPlJCervical infection of oncogenic human papillomavirus (HPV) types in Beijing, ChinaBiomed Environ Sci2016291073474127927273
- ZhaoFHLewkowitzAKHuSYPrevalence of human papilloma-virus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studiesInt J Cancer2012131122929293822488743
- Mulindi MwanahamuntuHHParhamGPHPV screening for cervical cancer in rural IndiaN Engl J Med20093613305306
- SchiffmanMWacholderSMark SchiffmanSWFrom India to the world−a better way to prevent cervical cancerN Engl J Med2009360141453145519339726
- SunPSongYRuanGClinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population studyJ Gynecol Oncol2017285e5028657218
- ZhaoJduHBelinsonJLEvaluation of The Cervista HPV A9 group in screening patients for cervical cancerJ Med Screen2016231384326466824
- RuanGSongYDongBCervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, ChinaCancer Manag Res2018103227323530233239
- KennedyAWSalmieriSSWirthSLBiscottiCVTuasonLJTravarcaMJResults of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screeningGynecol Oncol199663114188898161
- StolerMHSchiffmanMAtypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) GroupInterobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage StudyJAMA2001285111500150511255427
- ScheungraberCKleekampNSchneiderAManagement of low-grade squamous intraepithelial lesions of the uterine cervixBr J Cancer200490597597814997192
- TrachtJMDavisADFascianoDNEltoumIADiscrepant HPV/cytology co-testing results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?Cancer Cytopathol20171251079580528817235
- SideriMIgidbashianSBoveriSAge distribution of HPV genotypes in cervical intraepithelial neoplasiaGynecol Oncol2011121351051321396686
- LiZMZengLQPengXHAnalysis of clinical and pathological characteristics of high-risk HPV-negative carcinoma of the uterine cervixZhonghua Fu Chan Ke Za Zhi201651968368727671050
- LiuHFLiuMXuYLYlXAnalysis of high-risk HPV infection and cervical cytologic screening in HIV positive womenZhonghua Fu Chan Ke Za Zhi2016511073473827788739
- LiuBWuZNLiuXYDistribution of human papillomavirus (HPV) among HPV positive cervical adenocarcinoma cases detected by laser capture microdissection (LCM)Zhonghua Zhong Liu Za Zhi201638427728227087374
- WuQZhaoXFuYA cross-sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese womenCancer Med2017651091110128378404
- BoersASlagter-MenkemaLvan HemelBMComparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-offPLoS One201497e10193025051098